2005
DOI: 10.1080/08035250510042951
|View full text |Cite
|
Sign up to set email alerts
|

Haematological parameters of HIV‐1‐uninfected infants born to HIV‐1‐infected mothers

Abstract: ART is successful in preventing MTCT, but alterations in haematological parameters may persist for a long period. The clinical implications remain uncertain. This suggestion increases the importance to continue prospective follow-up on the haematological parameters in ART/HIV-exposed children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
46
2
4

Year Published

2008
2008
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(53 citation statements)
references
References 30 publications
(34 reference statements)
1
46
2
4
Order By: Relevance
“…Lower hemoglobin levels and neutropenia (12,13) have been shown previously in infants exposed in utero to antiretroviral drugs. In a recent publication, different antiretroviral schemes led to diverse toxic effects (14).…”
Section: Discussionmentioning
confidence: 99%
“…Lower hemoglobin levels and neutropenia (12,13) have been shown previously in infants exposed in utero to antiretroviral drugs. In a recent publication, different antiretroviral schemes led to diverse toxic effects (14).…”
Section: Discussionmentioning
confidence: 99%
“…Also, the antiretroviral (ARV) prophylaxis of vertical transmission can act on the placental environment, causing changes in cytokine expression (9). The newborns present abnormalities in mitochondrial function (2), in hematological features (5,10,17), and in the maturation of T and B lymphocytes (3,4,8,11,12,20,24,25).…”
mentioning
confidence: 99%
“…Cette atteinte modeste, mais très significative sur le plan statistique, signe une altération des cellules souches hématopoïétiques. Nous avons pu montrer que ces cellules souches CD34 + sont le siège d'altérations fonctionnelles et que leur profil de transcription génique est compatible avec un processus de réparation de l'ADN [30][31][32]. De nouvelles données de notre laboratoire sur le caractère génotoxique de la zidovudine chez l'enfant exposé in utero ne font que renforcer le questionnement de la tolérance à long terme de ce traitement.…”
Section: Référencesunclassified